Cardiovascular Intervention and Therapeutics最新文献

Impact of pullback speed on evaluation of lipid core plaque using near-infrared spectroscopy-intravascular ultrasound.

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2025-04-03 DOI: 10.1007/s12928-025-01124-7

Tetsuharu Kasahara, Hideki Kitahara, Kenta Takou, Kazuya Tateishi, Yuichi Saito, Ken Kato, Takashi Iimori, Yoshio Kobayashi

{"title":"Impact of pullback speed on evaluation of lipid core plaque using near-infrared spectroscopy-intravascular ultrasound.","authors":"Tetsuharu Kasahara, Hideki Kitahara, Kenta Takou, Kazuya Tateishi, Yuichi Saito, Ken Kato, Takashi Iimori, Yoshio Kobayashi","doi":"10.1007/s12928-025-01124-7","DOIUrl":"https://doi.org/10.1007/s12928-025-01124-7","url":null,"abstract":"Near-infrared spectroscopy-intravascular ultrasound (NIRS-IVUS) can assess the amount of lipid core plaque, and the latest generation catheter allows for imaging at several different pullback speeds. The purpose of this study was to investigate the impact of pullback speed on evaluation of lipid core plaque using the latest generation NIRS-IVUS catheter. Patients with coronary artery disease who underwent coronary angiography or percutaneous coronary intervention with NIRS-IVUS examination at 2 different pullback speeds (0.5 and 2.0 mm/sec) for the same vessel were enrolled. The values of lipid core burden index (LCBI) and maxLCBI4mm were compared between the images recorded with pullback speeds of 0.5 and 2.0 mm/sec, and match or mismatch of the location where maxLCBI4mm was detected was investigated. In a total of 286 NIRS-IVUS image sets, the location of maxLCBI4mm measured at 0.5 and 2.0 mm/sec was mismatched in 81 (28.3%) image sets. In comparison by vessel type, 20.8% were mismatched in LAD, 31.1% in LCx, and 37.8% in RCA (p = 0.023). In 205 image sets with matched maxLCBI4mm location, the maxLCBI4mm value at 2.0 mm/sec was significantly greater compared with that at 0.5 mm/sec (348.0 vs. 302.0 in median, p < 0.001). In a substantial proportion of patients, the location of maxLCBI4mm values measured at 0.5 and 2.0 mm/sec was mismatched. In the image sets with matched maxLCBI4mm location, the maxLCBI4mm value at 2.0 mm/sec was significantly greater compared with that at 0.5 mm/sec. These results should be noted when applying the cut-off values of maxLCBI4mm recorded at 2.0 mm/sec.","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143771276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A serial evaluation of endovascular treatment for pulmonary vein stenosis following pulmonary vein isolation using exercise stress echocardiography.

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2025-04-02 DOI: 10.1007/s12928-025-01125-6

Mamiko Yamada, Yasuhide Mochizuki, Saeko Kurobe, Yuya Nakamura, Hiroto Fukuoka, Toshiro Shinke

引用次数: 0

Clinical outcome after bleeding events following coronary stenting in patients with and without comorbid peripheral arterial disease. 伴有或不伴有外周动脉疾病患者冠状动脉支架植入术后出血事件的临床结果

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2025-04-01 Epub Date: 2024-12-19 DOI: 10.1007/s12928-024-01073-7

Tineke H Pinxterhuis, Eline H Ploumen, Marlies M Kok, Carl E Schotborgh, Rutger L Anthonio, Ariel Roguin, Peter W Danse, Edouard Benit, Adel Aminian, Marc Hartmann, Gerard C M Linssen, Robert H Geelkerken, Carine J M Doggen, Clemens von Birgelen

{"title":"Clinical outcome after bleeding events following coronary stenting in patients with and without comorbid peripheral arterial disease.","authors":"Tineke H Pinxterhuis, Eline H Ploumen, Marlies M Kok, Carl E Schotborgh, Rutger L Anthonio, Ariel Roguin, Peter W Danse, Edouard Benit, Adel Aminian, Marc Hartmann, Gerard C M Linssen, Robert H Geelkerken, Carine J M Doggen, Clemens von Birgelen","doi":"10.1007/s12928-024-01073-7","DOIUrl":"10.1007/s12928-024-01073-7","url":null,"abstract":"Patients undergoing percutaneous coronary intervention (PCI) may experience bleeding events. Bleeding risk is increased in patients with comorbid peripheral arterial disease (PADs). To evaluate whether PCI patients with PADs have worse outcome after bleeding, we assessed pooled patient-level data of 5,989 randomized all-comer trial participants and identified those who had a bleeding (BIO-RESORT:NCT01674803, BIONYX:NCT02508714). Major adverse cardiac events (MACE) and mortality were assessed from bleeding until 3 years after PCI. Of all 313 PCI patients with bleeding events, patients with PADs (n = 34, 10.9%) were older and had more complex lesions than those without PADs (n = 279, 89.1%). In patients with PADs, bleeding occurred more often during the first year after PCI (79.4% vs. 57.3%, p = 0.013). The proportion of major bleeding, and the severity and location of bleeding were similar between both groups. Multivariate analysis found no statistically significant between-group difference in MACE (43.1% vs. 34.7%, p = 0.53; adj.HR:0.86, 95%CI 0.45-1.63, p = 0.64) and mortality (33.5% vs. 22.3%, p = 0.12; adj.HR:1.45, 95%CI 0.73-2.91, p = 0.29). Bleeding occurred significantly more often during the first year after PCI in all-comer patients with concomitant PADs than in those without PADs, while we observed no significant between-group difference in bleeding severity and location, and the risk of adverse events after bleeding.","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":"287-295"},"PeriodicalIF":3.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142853001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Sex-related outcomes after percutaneous coronary intervention of in-stent restenosis.

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2025-04-01 Epub Date: 2025-02-03 DOI: 10.1007/s12928-025-01092-y

Constantin Kuna, Christian Bradaric, Mira Schroeter, Antonia Presch, Felix Voll, Sebastian Kufner, Tareq Ibrahim, Heribert Schunkert, Karl-Ludwig Laugwitz, Salvatore Cassese, Adnan Kastrati, Jens Wiebe

{"title":"Sex-related outcomes after percutaneous coronary intervention of in-stent restenosis.","authors":"Constantin Kuna, Christian Bradaric, Mira Schroeter, Antonia Presch, Felix Voll, Sebastian Kufner, Tareq Ibrahim, Heribert Schunkert, Karl-Ludwig Laugwitz, Salvatore Cassese, Adnan Kastrati, Jens Wiebe","doi":"10.1007/s12928-025-01092-y","DOIUrl":"10.1007/s12928-025-01092-y","url":null,"abstract":"Limited data are available for sex-related long-term outcomes of patients treated for coronary drug-eluting stent (DES) restenosis. The aim of this observational, retrospective analysis was to close this lack of evidence. Between January 2007 and February 2021, a total of 3511 patients with 5497 in-stent restenosis (ISR) lesions were treated at two large-volume centers in Munich, Germany, of which 763 (21.7%) were female. Endpoints of interest were all-cause mortality and rates of repeat revascularization. Outcomes are presented as Kaplan-Meier event rates. Univariate and multivariate analyses were performed. Female patients were older (72.1 ± 10.4 versus 68.4 ± 10.4 years, p < 0.001) and suffered more often from diabetes (38.8% versus 34.4%, p = 0.029). There was no statistical difference regarding the clinical presentation and interventional treatment strategy. After 10 years, the risk of all-cause mortality was higher in female patients [hazard ratio (HR) 1.18 (1.02-1.35); p = 0.022]; however, after adjustment for age, the risk did not differ significantly between both sexes [adjusted HR 0.96 (0.83-1.11); p = 0.6]. Regarding target vessel revascularization (TVR) and non-target vessel revascularization (NTVR), the risk was lower in female patients [HR 0.73 (0.61-0.87); p < 0.001 and HR 0.74 (0.64-0.86); p < 0.001] even after age adjustment. No statistical differences were found regarding the risk of target lesion revascularization, target vessel myocardial infarction and stent thrombosis. In the long term, all-cause mortality after percutaneous coronary intervention of DES-ISR did not differ between both sexes after age adjustment. The risk of TVR and NTVR was lower in female patients even after age adjustment.","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":"316-326"},"PeriodicalIF":3.1,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11910406/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143078722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Trans-ankle intervention assisted ultrasound-guided thrombin injection for iatrogenic femoral artery pseudoaneurysm. 经踝介入辅助超声引导凝血酶注射治疗先天性股动脉假性动脉瘤。

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2025-04-01 Epub Date: 2024-10-26 DOI: 10.1007/s12928-024-01055-9

Tetsuya Nomura, Michitaka Kitamura, Shiori Yoshida, Keisuke Shoji, Yukinori Kato, Naotoshi Wada

引用次数: 0

Intravascular ultrasound can distinguish between thrombus formation and coronary vasospasm during primary percutaneous coronary intervention.

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2025-04-01 Epub Date: 2025-01-24 DOI: 10.1007/s12928-025-01098-6

Shun Ishibashi, Kenichi Sakakura, Hideo Fujita

引用次数: 0

Usefulness of cardiac computed tomography imaging for detecting mitral chordae tendineae in patients undergoing transcatheter edge-to-edge repair: a case report.

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2025-04-01 Epub Date: 2025-01-27 DOI: 10.1007/s12928-025-01086-w

Hiroki Wabiko, Kenta Yoshikawa, Ryo Nishikawa, Nobuaki Kokubu, Shogo Misumi, Masato Furuhashi

引用次数: 0

Transcatheter edge-to-edge repair for acute mitral valve regurgitation due to papillary muscle rupture in cardiogenic shock patient with acute myocardial infarction. 经导管边缘对边缘修补术治疗急性心肌梗死心源性休克患者乳头肌断裂导致的急性二尖瓣反流。

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2025-04-01 Epub Date: 2024-10-22 DOI: 10.1007/s12928-024-01050-0

Yoshikazu Ohara, Yuki Yoshimura, Yohko Fukuoka, Satoshi Kawada, Katsuhito Yamamoto

引用次数: 0

Uncrossable aortic stenosis during transcatheter aortic valve replacement: application of balloon-assisted tracking technique. 经导管主动脉瓣置换术中无法穿越的主动脉瓣狭窄：球囊辅助追踪技术的应用。

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2025-04-01 Epub Date: 2024-10-29 DOI: 10.1007/s12928-024-01056-8

Jiawei Zhou, Yuehuan Li, JianGang Wang, Haibo Zhang

引用次数: 0

Iatrogenic aorto-coronary dissection triggered by contrast injection during coronary evaluation with optical frequency domain imaging. 在冠状动脉光学频域成像评估时，造影剂注射引发的医源性主动脉-冠状动脉夹层。

IF 3.1

Cardiovascular Intervention and Therapeutics Pub Date : 2025-04-01 Epub Date: 2025-01-13 DOI: 10.1007/s12928-025-01085-x

Yosuke Takei, Teruo Sekimoto, Tokutada Sato, Hiroyoshi Mori, Hiroshi Suzuki

引用次数: 0